Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

NCT01199887 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: IW001

Sponsor

ImmuneWorks